Amid “positive data” emerging from a clinical trial, the U.S. Food and Drug Administration is expected to authorize emergency use of the antiviral drug remdesivir…
Posts tagged as “Gilead Sciences’ experimental U.S. antiviral drug”
FTSE 100 in ‘bull market’ territory as Covid-19 treatment hopes lift shares – business live
April 29, 2020
Britain’s blue-chip index has jumped back over 6,000 points, after biopharmaceutical company Gilead reported positive results for its remdesivir drug Latest: FTSE 100 jumps 2.6%…
“It’s Quite Good News” – Stocks Surge As Fauci Praises Own Remdesivir Study, Talks Down Lancet Findings
April 29, 2020
Investors are struggling to decipher the significance of clashing scientific studies about the prospects of Gilead Sciences’ potential coronavirus drug, which has been touted as…
China lab seeks patent on use of Gilead’s coronavirus treatment
February 5, 2020
BEIJING/SHANGHAI – A state-run Chinese research institute has applied for a patent on the use of Gilead Sciences’ experimental U.S. antiviral drug, which scientists think…